Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06712719 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Dietary Phosphorus on Phosphorus and Calcium Whole-Body Balance and Kinetics in Moderate CKD

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date pushed from Oct 1, 2026 to Nov 1, 2026
    • Eligibility criteria expanded, about 16 words
  2. Start date: Sep 1, 2026 to Oct 1, 2026v12
  3. Start date: Jun 2026 to Sep 1, 2026v11
  4. Start date: May 1, 2026 to Jun 2026
    • Study sites: 0 to 1
    • Primary and study completion dates: May 28, 2027 to May 2027
    • Collaborators expanded, about 2 words
    v10
  5. Start date: Mar 1, 2026 to May 1, 2026v9
Show 7 earlier versionsHide 7 earlier versions
  1. Start date: Feb 1, 2026 to Mar 1, 2026v8
  2. Enrollment target: 22 to 14
    • Secondary endpoints: 14 to 13
    • Study description expanded, about 1 word
    v7
  3. Start date: Oct 1, 2025 to Feb 1, 2026v6
  4. Start date: Jul 1, 2025 to Oct 1, 2025v5
  5. Start date: Apr 1, 2025 to Jul 1, 2025
    • Primary and study completion dates: Feb 28, 2027 to May 28, 2027
    v4
  6. Start date: Feb 1, 2025 to Apr 1, 2025
    • Primary and study completion dates: Dec 31, 2026 to Feb 28, 2027
    v3
  7. Phase: Phase 2 to Not applicable
    • Start date: Jan 1, 2025 to Feb 1, 2025
    • Eligibility criteria shortened, about 7 words
    • Study description expanded, about 296 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to look at the effects of dietary phosphorus on phosphorous and calcium whole-body balance and kinetics in moderate chronic kidney disease (CKD). N = 14 enrolled subjects will be randomly assigned to a cross-over order of (A) Low P Diet, High P Diet. Each cross-over phase will be 19 days and consist of a 7-day outpatient, controlled diet period, followed by a 5- day inpatient, controlled diet, balance, and kinetic study period, followed by a second 7-day outpatient, controlled diet period.
Trial Details
NCT Number NCT06712719
Lead Sponsor University of Minnesota
Collaborators: Indiana University
Conditions
(from sponsor)		 CKD
Enrollment 14 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov